These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 29282215

  • 1. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.
    Rey FA, Stiasny K, Vaney MC, Dellarole M, Heinz FX.
    EMBO Rep; 2018 Feb; 19(2):206-224. PubMed ID: 29282215
    [Abstract] [Full Text] [Related]

  • 2. The role of anti-flavivirus humoral immune response in protection and pathogenesis.
    Hurtado-Monzón AM, Cordero-Rivera CD, Farfan-Morales CN, Osuna-Ramos JF, De Jesús-González LA, Reyes-Ruiz JM, Del Ángel RM.
    Rev Med Virol; 2020 Jul; 30(4):e2100. PubMed ID: 32101633
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cross-Reactive Immunity Among Flaviviruses.
    Rathore APS, St John AL.
    Front Immunol; 2020 Jul; 11():334. PubMed ID: 32174923
    [Abstract] [Full Text] [Related]

  • 5. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
    Malafa S, Medits I, Aberle JH, Aberle SW, Haslwanter D, Tsouchnikas G, Wölfel S, Huber KL, Percivalle E, Cherpillod P, Thaler M, Roßbacher L, Kundi M, Heinz FX, Stiasny K.
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766
    [Abstract] [Full Text] [Related]

  • 6. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.
    Pierson TC, Fremont DH, Kuhn RJ, Diamond MS.
    Cell Host Microbe; 2008 Sep 11; 4(3):229-38. PubMed ID: 18779049
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
    Pierson TC, Diamond MS.
    Expert Rev Mol Med; 2008 May 12; 10():e12. PubMed ID: 18471342
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A, Matsuda M, Okabayashi T, Pitaksajjakul P, Ramasoota P, Saito K, Fukasawa M, Hanada K, Matsuura T, Muramatsu M, Shioda T, Suzuki R.
    mSphere; 2021 Aug 25; 6(4):e0033921. PubMed ID: 34259560
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.
    Pierson TC, Diamond MS.
    Prog Mol Biol Transl Sci; 2015 Aug 25; 129():141-66. PubMed ID: 25595803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.